Inhibitor Therapeutics Inc. (INTI)
Market Open
7 Oct, 08:00 PM
OTCQB OTCQB Primary 
PSX $
0. 10
0
0%
$
16.91M Market Cap
- P/E Ratio
- Div Yield
1,000 Volume
0 Eps
$ 0.1
Previous Close Want to track INTI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Inhibitor Therapeutics Inc. (INTI) Statistics
Valuation metrics
Market Cap 16.91M
Enterprise value 16.44M
Trailing P/E (ttm) -5.13
Forward P/E -
PEG ratio -1.14
Price/Sales (ttm) -
Price/Book (mrq) -6.64
Enterprise Value/Revenue -
Enterprise Value/EBITDA -4.92
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.09K
Average volume (90 days) 7.9K
Price summary
52-Week low 0.04
52-Week high 0.12
Beta -
50-Day moving average 0.09
200-Day moving average 0.09
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -5.19%
Return on equity 2.27%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.02
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0
Total debt (mrq) -
Total Debt/Equity (mrq) -0.02
Current ratio (mrq) 3.36%
Book value per share (mrq) -0.01
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
